Pentoxifylline

Mechanism of action and vascular effects

The pharmacodynamics of pentoxifylline is based on its ability to block adenosine receptors and inhibit the activity of the phosphodiesterase enzyme. This leads to a significant intracellular accumulation of cyclic adenosine monophosphate (cAMP) in the smooth muscle elements of the vascular wall.

The result of this biochemical cascade is muscle relaxation and moderate dilation of the blood vessel lumen. Structurally, the active substance belongs to xanthine derivatives and exhibits clear structural similarities to theophyllinum (theophylline).

Rheological effects and microcirculation

In addition to a direct effect on vascular tone, the drug radically alters the rheological parameters (flowability) of blood. Phosphodiesterase blockade and increased cAMP concentration inside platelets lead to a drop in cytoplasmic ionized calcium ($Ca^{2+}$) levels. As a result, platelet aggregation is significantly inhibited.

An extremely important effect is the increase in the deformability of erythrocytes. The improved elasticity of red blood cell membranes allows them to pass more easily through narrow capillaries. Together, these processes lead to:

• A pronounced decrease in blood viscosity.
• Normalization of microcirculation processes.
• Optimization of oxygen delivery to tissues.

During parenteral (intravenous) administration, stimulation of collateral (bypass) blood flow is also noted — the volumetric rate of circulation increases. Additionally, a metabolic effect is realized, manifested in an increase in ATP content in brain neurons.

Indications and dosing regimens

The main indications for prescribing the drug are ischemic circulatory disorders of various etiologies. The drug works in three key vascular beds:

1. Cerebral.
2. Coronary.
3. Peripheral.

The agent is also actively used in vascular pathology of the organ of vision.

The route of administration depends on the severity of the patient's condition:

• Oral administration: enteric-coated tablets are taken orally after meals. They must be swallowed whole without chewing, washed down with plenty of water. Standard forms are prescribed 3 times a day, prolonged-release forms 2 times a day.
• Parenteral administration: intravenous drip infusions are used as needed, typically for severe disease courses.

Side effects and overdose symptoms

Therapy with xanthine derivatives may be accompanied by a number of adverse events from various body systems:

• Cardiovascular system and skin: tachycardia, sharp drop in blood pressure (especially with IV administration), sensation of warmth, hyperemia (redness) of the face and upper chest. There is a risk of bleeding from mucosal and skin vessels.
• Gastrointestinal tract: dyspeptic disorders, including nausea and vomiting.
• Central nervous system: bouts of dizziness.
• Immune system: allergic reactions.

Important: Similar to dipyridamole, pentoxifylline can provoke the development of steal syndrome, which clinically manifests as acute attacks of angina pectoris.

In case of overdose, the patient develops critical hypotension, hyperthermia (fever), loss of consciousness, seizure activity, and massive gastrointestinal bleeding. Emergency care consists of gastric lavage, administration of enterosorbents (activated charcoal), and supportive care for vital functions (respiration and blood pressure).

Position in the vasodilator classification

Drugs that improve cerebral circulation are divided into several pharmacological groups. Pentoxifylline is the main representative of the xanthine derivative class. For comparison, the following are also used in clinical practice:

• Periwinkle alkaloid derivatives (e.g., vinpocetine, which does not cause the "steal" phenomenon);
• Ergot alkaloid derivatives (nicergoline with combined alpha-adrenolytic and myotropic action);
• Nicotinic acid derivatives (xanthinol nicotinate, combining the properties of a vitamin and theophylline);
• Calcium channel blockers (cinnarizine) and GABA derivatives.

Knowledge of this classification allows the physician to individually select optimal angioprotective therapy depending on the pathology.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Vinpocetine pharmacology: absence of the "steal" phenomenon and effects on neuronal metabolism.
• Nicergoline: mechanism of alpha-blocking and myotropic action of ergot alkaloid derivatives.
• Xanthinol nicotinate: synergism of nicotinic acid and theophylline in correcting cerebral hypoxia.
• Steal syndrome: pathophysiology using vasodilators (pentoxifylline, dipyridamole) as an example.
• Comparative characteristics of angioprotectors (rutoside, Detralex, calcium dobesilate) in venous insufficiency.

Other topics in the «Drugs and Prescriptions» section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.